Brain-shuttle technology: expert insights
Following the first regulatory approval of a brain-shuttled drug, Denali's Avlayah (tividenofusp alfa-eknm), and a surge of billion-dollar deal-making in the field, our research will examine which platforms and therapeutic approaches are positioned to lead.
Qualitative 60-minute interviews with 10 brain-shuttle research experts, drawn from both academia and industry.
Pre-purchase to add up to three complimentary proprietary questions.
Topics covered in this report
Brain-shuttle TechnologyThis report maps the current landscape and projected future outlook for brain-shuttle technology, identifying where companies can enter or expand in the space.
- Which CNS-shuttle targets have been identified to-date?
- What proof-of-concept has been established?
- What are the merits and drawbacks of each shuttle?
- How does the choice of shuttle depend on the type of disease being targeted and therapy being delivered?
- What criteria should be considered in identifying a promising CNS-shuttle?
- What is the competitive landscape of CNS-shuttled drugs in development by disease?
- What clinical and commercial benefits do KOLs expect from the therapies approaching key readouts and approvals?
- In diseases where non-shuttle approaches exist, how do shuttle-enabled therapies compare on efficacy, safety and delivery?
- What are the leading companies in the CNS-shuttle space?
- What are the benchmarks in terms of deal-making for CNS-shuttle technologies?
- What do the current flow of deals tell us about which targets and platforms the market is betting on?
- How do we project the CNS-shuttle space will evolve in the next 5-10 years?
- What are the limitations to current CNS-shuttle technologies that could be overcome by next generation approaches?
- What developments and key upcoming readouts are shuttle technology experts closely watching as indicators of where the field is going?
Add complimentary proprietary questions
Pre-purchase
Buy the brain-shuttle syndicated report to add your own proprietary questions.
Submit up to three
We review, refine and finalize your questions with you.
Receive insights
A dedicated summary of the answers to your proprietary questions will be delivered in addition to the full report.
Talk to our team about the brain-shuttle report
Pre-purchase the syndicated report, add your proprietary questions, and get intelligence tailored to your priorities.
Qualitative 60-minute interviews with 10 brain-shuttle research experts, drawn from both academia and industry.
- PowerPoint report of key findings
- Custom analysis of proprietary questions
- Presentation tailored to your priorities